CLINICAL_TRIALS
ClinicalTrials.gov record update
Thrombokinetic Studies of Ado-Trastuzumab Emtansine
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01816035
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:33.680771+00:00
- Published At
- 2017-05-23T00:00:00+00:00
- Record Updated At
- 2017-05-23
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["HER2/Neu Positive", "Recurrent Breast Carcinoma", "Stage IIIB Breast Cancer", "Stage IIIC Breast Cancer", "Stage IV Breast Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-05-23"- protocolSection.identificationModule.nctId
"NCT01816035"- protocolSection.identificationModule.officialTitle
"Thrombokinetic Studies of Ado-Trastuzumab Emtansine"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.